Trademark: 87344991
Word
ORISVIO
Status
Registered
Status Code
700
Status Date
Tuesday, May 22, 2018
Serial Number
87344991
Registration Number
5472768
Registration Date
Tuesday, May 22, 2018
Mark Type
4000
Filing Date
Wednesday, February 22, 2017
Published for Opposition
Tuesday, March 6, 2018

Trademark Owner History
Actelion Pharmaceuticals Ltd - Original Registrant

Classifications
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical anti-allergic preparations and substances; vaccines

Trademark Events
May 22, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 22, 2018
Registered-Principal Register
Mar 6, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 6, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 6, 2018
Official Gazette Publication Confirmation E-Mailed
Mar 6, 2018
Published For Opposition
Feb 14, 2018
Notification Of Notice Of Publication E-Mailed
Jan 29, 2018
Approved For Pub - Principal Register
Jan 11, 2018
Teas/Email Correspondence Entered
Jan 11, 2018
Correspondence Received In Law Office
Jan 3, 2018
Teas Response To Office Action Received
Nov 6, 2017
Notification Of Non-Final Action E-Mailed
Nov 6, 2017
Non-Final Action E-Mailed
Nov 6, 2017
Non-Final Action Written
Oct 16, 2017
Teas/Email Correspondence Entered
Oct 16, 2017
Correspondence Received In Law Office
Oct 10, 2017
Assigned To Lie
Sep 27, 2017
Teas Response To Office Action Received
May 9, 2017
Notification Of Non-Final Action E-Mailed
May 9, 2017
Non-Final Action E-Mailed
May 9, 2017
Non-Final Action Written
May 8, 2017
Assigned To Examiner
Feb 28, 2017
New Application Office Supplied Data Entered
Feb 25, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24